Clinical Trials on LGMD in Canada

Total 2 results

Sunnybrook Health Sciences Centre
Seagen Inc.; Biocon Biologics

Recruiting

Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD

HER2-positive Breast Cancer | LMD

Canada
Sarepta Therapeutics, Inc.

Recruiting

A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Limb-girdle Muscular Dystrophy

United States, Brazil, Belgium, Canada, Germany, Italy, Spain, Sweden, Turkey, United Kingdom

3

Subscribe